|
|
|
|
LEADER |
01194naa a2200301 i 4500 |
001 |
NSK01000902733 |
003 |
HR-ZaNSK |
005 |
20150911141049.0 |
007 |
ta |
008 |
150326s2013 ci | |0|| ||eng |
035 |
|
|
|a (HR-ZaNSK)000902733
|
040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
042 |
|
|
|a croatica
|
044 |
|
|
|a ci
|c hr
|
080 |
1 |
|
|a 54
|2 MRF 2011.
|
080 |
1 |
|
|a 615
|2 MRF 2011.
|
100 |
1 |
|
|a Aliabadi, Alireza
|
245 |
1 |
0 |
|a Synthesis, cytotoxicity assessment, and molecular docking of 4-substituted-2-p-tolylthiazole derivatives as probable c-Src and erb tyrosine kinase inhibitors /
|c Alireza Aliabadi, Alireza Foroumadi, Maliheh Safavi, Sussan K. Ardestani.
|
300 |
|
|
|b Ilustr.
|
504 |
|
|
|a Bibliografija: 15 jed.
|
653 |
|
0 |
|a Feniltiazol
|a Citotoksičnost
|a Inhibitori tirozin-kinaze
|a Protutumorsko djelovanje
|a Protutumorski lijekovi
|a Rak dojke
|
700 |
1 |
|
|a Foroumadi, Alireza
|
700 |
1 |
|
|a Safavi, Maliheh
|
700 |
1 |
|
|a Ardestani, Sussan K.
|
773 |
0 |
|
|t Croatica chemica acta
|x 0011-1643
|g 86 (2013), 3 ; str. 245-251
|
981 |
|
|
|b B10/13
|p CRO
|
998 |
|
|
|a milo150326
|
856 |
4 |
2 |
|u http://hrcak.srce.hr/index.php?show=clanak&id_clanak_jezik=163936
|y Elektronička verzija članka
|